Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06929390 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Comparing BTVA and MWA in COPD With Early Lung Cancer: Efficacy and Safety

StatusNot Yet Recruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

  1. Re-verified, no change to tracked fieldsv2
  2. Study First Submitted
Based on the advantages of BTVA in the treatment of early-stage lung cancer and COPD, researchers propose the concept of using BTVA to treat COPD combined with early-stage lung cancer. Researchers plan to conduct a multicenter clinical study focusing on patients with COPD combined with malignant GGNs. Bronchoscopic BTVA surgery or percutaneous MWA surgery will be performed, evaluating the effectiveness and safety of bronchoscopic BTVA and percutaneous MWA surgery in the treatment of COPD combined with early-stage lung cancer.
Trial Details
NCT Number NCT06929390
Lead Sponsor Henan Provincial People's Hospital
Conditions
(from sponsor)		 Copd, Lung Cancer
Related terms Lung Neoplasms, Pulmonary Disease, Chronic Obstructive
Enrollment 26 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov